Sees FY25 adjusted EBITDA $850M-$900M. Sees FY25 capital expenditures $285M. The company said, “Adient’s (ADNT) ability to execute operationally underpinned the company’s ability to generate strong free cash flow, which was returned to shareholders through the company’s disciplined capital allocation strategy.”
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter